Segal Trials
Giovanna Auerbach is the Director of Regulatory and Compliance at Segal Trials and the Chief Executive Officer at ValTech Development. Previously, at WCCT Global, Giovanna held positions as Associate Director of Quality Control & Compliance and Associate Director of E-Source Management. With experience as a QA Manager at OmniComm Systems, Giovanna has a Bachelor of Science in Criminal Justice from Florida International University.
This person is not in the org chart
This person is not in any teams
Segal Trials
1 followers
Segal Trials, founded in 1998, is a privately held network of seven research sites throughout South Florida conducting Phase I-IV research trials with a primary emphasis on psychiatry, neurology, addiction, insomnia, general medicine, healthy volunteers, infectious diseases, vaccines, and women’s health. Staying true to its core values of quality, customer service, advocacy, and patient care, the Segal Trials team of over 110 professionals remains agile and competitive, expanding and growing based on the needs of its sponsors and its patients. Federal law requires that every medication must go through a series of clinical research trials before being approved by the FDA, in addition to being approved by an independent Research Ethics Board. Clinical research trials are critical in the advancement of medicine and making available new and helpful medications. It is Segal Trials’ mission to play an integral role in the advancement process and help millions of people suffering from diseases.